May 14, 2024 · Form 4 insider transaction
Thackray Helen M. bought 30,000 shares of BioCryst Pharmaceuticals, Inc. at $5.86 per share, a transaction worth $175.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.84 to $5.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.